In lieu of an abstract, here is a brief excerpt of the content:

  • Contributors

Nikola BILLER-ANDORNO directs the Institute of Biomedical Ethics of the University of Zurich, Switzerland (www.ethik.uzh.ch/ibme), a WHO Collaborating Centre for Bioethics, as well as the PhD program “Biomedical Ethics and Law” (medical track) (www.bmel.uzh.ch/med). She has acted as deputy editor of the Journal of Medical Ethics, and is the immediate Past-President of the International Association of Bioethics. She is a 2012–13 Commonwealth Fund Harkness Fellow and Visiting Professor of Biomedical Ethics at Harvard University.

Hitoshi ARIMA is Associate Professor of Moral Philosophy and Applied Ethics at Yokohama City University Graduate School of Urban Social and Cultural Studies, Yokohama, Japan. He is also a member of the ethics committee of Yokohama Rosai Hospital, Yokohama, Japan. Dr. Arima has published in the fields of applied ethics and meta-ethics. His research interests in bioethics include ethics of killing, post-humous interest, and other end-of-life related issues. His recent publications include a book (co-authored with Shin’ya Tateiwa) entitled Discussions and Practices of Life and Death, Vol. 1 (Seikatsu Shoin, 2012, in Japanese).

Benjamin J. CAPPS is an Assistant Professor at the Centre for Biomedical Ethics, Yong Loo Lin School of Medicine, National University of Singapore, where he is Director of Graduate Studies. Dr. Capps is a member of the Human Genome Organisation’s (HUGO) Committee on Ethics, Law and Society; the Pro-Tem National Oversight Committee for Human Animal Combinations in Stem Cell Research (Ministry of Health, Singapore); and the Neuroethics Working Group of the Bioethics Advisory Committee (Singapore).

Bahaa DARWISH is a Professor of Philosophy at Minia University, Egypt. He has participated in numerous local, regional and international conferences covering a wide range of philosophical issues, including theory of knowledge, philosophy of mind, philosophy of language, critical thinking, bioethics, and ethics of science and technology. In 2009, he participated in preparing the Qatar University Handbook for Research Ethical Rules and Regulations. Dr. Darwish was involved in founding, and is now a board member of, the International Association for Education in Ethics (http://www.duq.edu/healthcare-ethics/iaee).

GAN Celestine Jian Xin is a Research Assistant at the Duke-NUS Graduate Medical School, Singapore. Prior to joining Duke-NUS, she was a student of the Nanyang Technological University, Singapore, where she majored in Biological Sciences.

JIN Pingyue is a PhD candidate at the Institute of Biomedical Ethics, University of Zurich, Switzerland. She obtained the Erasmus Mundus Master of Bioethics in 2010. pHer research primarily focuses on ethical issues of healthcare financing systems, especially the recent provider payment reform in China, but her interests extend to [End Page 169] relevant areas such as social justice, public health ethics, empirical bioethics, health technology assessment, and ethics of novel technology.

LEE Tih Shih graduated with an MD and a PhD from Yale University and completed his residency in psychiatry there. He is US board certified in psychiatry and has sub-specialty certification in neuropsychiatry. He is currently an Associate Professor at Duke University, Durham, USA and Duke-NUS Graduate Medical School, Singapore. His areas of research are in neurocognitive disorders.

LIN Yun-Hsien Diana is an Associate Professor in the Institute of Law for Science and Technology (ILST) in National Tsing Hua University, Taiwan. Dr. Lin’s research interests are in the fields of family law, law of succession, biomedical laws, and gender and law. She is primarily interested in the impact brought by emerging medical technology to the traditional structure of family law and the regulation on reproductive medicine.

Tamra LYSAGHT is a Senior Research Fellow at the Asia Research Institute, Singapore. Her research interests broadly focus on the bioethical, regulatory and sociopolitical dimensions of translational science and emergent biomedical technologies, including stem cell science, genomics and reproductive health, and she is currently working on the development of governance models for the ethical conduct of biomedical experimentation within clinical contexts. She has previously held research positions at the Centre for Biomedical Ethics at the National University of Singapore and completed her PhD at the University of Sydney in association with the Unit for History and Philosophy of Science and the Centre for Values, Ethics and the Law in...

pdf

Share